The pharmaceutical world is witnessing a remarkable shift in glucose treatment with the introduction of GLP-1 patches. These systems offer a seemingly more convenient alternative to injections of GLP-1 drugs, lessening the frequency of daily needle pricks. The innovation delivers the compound directly through the skin, possibly enhancing individual